Science Discussion Forum

Welcome to the ACNP Science Discussion Forum. This feature is a fully public forum to enable discussion and comment by anyone about selected articles and presentations appearing in scientific journals, including our own journal, Neuropsychopharmacology, and media/Internet presentations. The Forum anticipates stimulating scholarly and collegial interactive discussions between authors, participants, producers, readers, or viewers of featured content and other scientists and researchers, with the intended aim of sharing such open dialogue with the public eager to be informed about and contribute to real-time scientific debate relating to research advances in psychiatric illness. This Forum is moderated of course, so there might be a short delay between promoting a comment on the website and its appearance in the discussion.

Featured Discussion

A Proposal for an Updated Neuropsychopharmacological Nomenclature

The taskforce on nomenclature of the four colleges – ECNP, ACNP, CINP and AsCNP is pleased to announce that we have reached the first stage of proposing pharmacologically-based principles for categorizing the most frequently used psychotropic drugs. We see this proposal as a demonstration of a principle and a "work in progress". Our expectation is that with help from the "expert wisdom" of our membership, using the same principle of Wikipedia, but with careful supervision and editing by the taskforce, it will be advanced and improved. Please review and provide your comments.

Archived Discussions

Dr. Marcia Angell and the Illusions of Anti-Psychiatry

In a special edition of the ACNP President's Blog for August 2012, Dr. John Krystal provides a response to two articles published in the New York Review of Books by Marcia Angell, former editor of the New England Journal of Medicine, that criticize the fields of psychiatry and psychopharmacology.  Please provide your own commentary on either Marcia Angell's articles or on John Krystal's response at the very end of this special blog.

Media Discussions

1-1 of 1 results.1

Article Discussions

1-5 of 8 results.12Next »

Association of the Anxiogenic and Alerting Effects of Caffeine with ADORA2A and ADORA1 Polymorphisms and Habitual Level of Caffeine Consumption

Peter J Rogers, Christa Hohoff, Susan V Heatherley, Emma L Mullings, Peter J Maxfield, Richard P Evershed, Jürgen Deckert, David J Nutt Neuropsychopharmacology

Child μ-Opioid Receptor Gene Variant Influences Parent–Child Relations

William E Copeland, Hui Sun, E Jane Costello, Adrian Angold, Markus A Heilig and Christina S Barr Neuropsychopharmacology

Repeated N-Acetyl Cysteine Reduces Cocaine Seeking in Rodents and Craving in Cocaine-Dependent Humans

Shelley L Amen, Linda B Piacentine, Muhammad E Ahmad, Shi-Jiang Li, John R Mantsch, Robert C Risinger and David A Baker Neuropsychopharmacology

Chronic High-Fat Diet Drives Postnatal Epigenetic Regulation of m-Opioid Receptor in the Brain

Zivjena Vucetic, Jessica Kimmel and Teresa M Reyes Neuropsychopharmacology

Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse

Robert A Moyer, Danxin Wang, Audrey C Papp, Ryan M Smith, Linda Duque, Deborah C Mash and Wolfgang Sadee Neuropsychopharmacology